This workshop has been organised by NewSouth Innovations Pty Ltd (NSi) and is intended to expand on last year’s general information workshop on “Commercialisation of Research at UNSW” and the role of NSi.

The idea of this workshop is to provide the FOM staff and researchers with specific real life examples of how to identify potentially valuable IP arising out of your research activities, the various modes of protection for this IP, and to discuss the challenges and commercialisation models/strategy around Diagnostics, Medical Devices & Software, and Therapeutics. We have invited a distinguished panel of experts from industry and academia to share their experiences in these areas and provide feedback and intelligence on how to maximise your interactions with biotechnology and pharmaceutical companies with the view of establishing long-term collaborations which will allow you to better identify commercial opportunities, potentially be a source of funding and expert opinion, and ultimately improve the quality and focus of your research.

EVENT AGENDA

NSi 2009 Faculty of Medicine Commercialisation Workshop Part Two:
Models and Challenges

Last year we introduced NSi, discussed its role and service offering, we covered the basic elements of commercialisation of research activities at UNSW; including IP policy, how to disclose to NSi, the general processes for assessing new opportunities, commercialisation options and the patenting process.

Scope: The 2009 Commercialisation Workshop will look more closely at the current models for commercialising different types of medical technologies and the associated issues and challenges.

Date: Thursday 23 April 2009

Target Audience: Intermediate to Advanced

Venue: Biomed F

Agenda

10:30am: Introduction by Prof Peter Smith, Dean of Medicine and Prof Denis Wakefield, Assoc Dean Research.

10:40am: Commercialising Therapeutics

i) “Commercialising therapeutics arising from academic labs and opportunities for university-industry partnerships in early drug development.”

NSi Introduction
ii) “Pharmageddon”: Presentation by Dr Susan Pond

11:10am: Commercialising Medical Devices and Software:
i) “Commercialising medical devices”.

NSi Introduction

ii) “Medical Devices Software: A developer’s perspective”
Presentation by Stephen Cocks, Invetech

11:40am: Biomarkers /Diagnostics and Theranostics: Key to the future of drug development.

i) “Biomarker Research and Challenges for Licensing”

NSi Introduction

ii) “Bringing Novel Diagnostics to Market”
Presentation by Mark Van Asten, CEO, Diagnostic Technologies

12:10pm: Q&A Panel: Dr Susan Pond, Stephen Cocks, Invetech, Mark Van Asten, CEO, Diagnostic Technologies, Phil Kearny, Director, Licensing & External Research, Merck.

12:30pm: Light Lunch and Networking

1:00pm: Close

Presentations:

Mark Van Asten presentation to UNSW FOM 23 Apr 2009

Stephen Cocks presentation to UNSW FOM 23 Apr 2009

Susan Pond presentation to UNSW FOM 23 Apr 2009

Contact:

Laura Issa BSc (Hon I) PhD MBT
Business Development Manager | Faculty of Medicine
T +61 2 9385 5592 | F +61 2 9385 6600 | M +61 410 607 458

l.issa@nsinnovations.com.au